ArticlePLoS biology2017
Prediction of drug cocktail effects when the number of measurements is limited.
Article in PLoS biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 41 citations in OpenAlex.
- Artificial intelligence applications in oxaliplatin-based chemotherapy for colon cancer: advancing prognosis, toxicity prediction, and dose personalization.Frontiers in pharmacology · 2026Review
- Drug combinations targeting antibiotic resistance.npj antimicrobials and resistance · 2024Review
- A continuous epistasis model for predicting growth rate given combinatorial variation in gene expression and environment.Cell systems · 2024Article
- Computational Advancements in Cancer Combination Therapy Prediction.JCO precision oncology · 2023Article
- Local generation and efficient evaluation of numerous drug combinations in a single sample.eLife · 2023Article
- Synergistic effects of complex drug combinations in colorectal cancer cells predicted by logical modelling.Frontiers in systems biology · 2023Article
- Systematic review of computational methods for drug combination prediction.Computational and structural biotechnology journal · 2022Review
- Article
- Multiobjective optimization identifies cancer-selective combination therapies.PLoS computational biology · 2020Article
- Enabling Technologies for Personalized and Precision Medicine.Trends in biotechnology · 2020Review
- Charting the Fragmented Landscape of Drug Synergy.Trends in pharmacological sciences · 2020Review
- Antibiotic interactions shape short-term evolution of resistance in E. faecalis.PLoS pathogens · 2020Article
- Article
- Pervasive and diverse collateral sensitivity profiles inform optimal strategies to limit antibiotic resistance.PLoS biology · 2019Article
- Bruton's tyrosine kinase is at the crossroads of metabolic adaptation in primary malignant human lymphocytes.Scientific reports · 2019Article
- Drug Combinations: Mathematical Modeling and Networking Methods.Pharmaceutics · 2019Review
- Noise-precision tradeoff in predicting combinations of mutations and drugs.PLoS computational biology · 2019Article
- Prediction of ultra-high-order antibiotic combinations based on pairwise interactions.PLoS computational biology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cocktails of drugs can be more effective than single drugs, because they can potentially work at lower doses and avoid resistance. However, it is impossible to test all drug cocktails drawn from a large set of drugs because of the huge number of combinations. To overcome this combinatorial explosion problem, one can sample a relatively small number of combinations and use a model to predict the rest. Recently, Zimmer and Katzir et al. presented a model that accurately predicted the effects of cocktails at all doses based on measuring pairs of drugs. This model requires measuring each pair at several different doses and uses interpolation to reduce experimental noise. However, often, it is not possible to measure each pair at multiple doses (for example, in scarce patient-derived tumor material or in large screens). Here, we ask whether measurements at only a single dose can also predict high-order drug cocktails. To address this, we present a fully factorial experimental dataset on all drug cocktails built of 6 chemotherapy drugs on 2 cancer cell lines. We develop a formula that uses only pair measurements at a single dose to predict much of the variation up to 6-drug cocktails in the present data, outperforming commonly used Bliss independence and regression approaches. This model, called the pairs model, is an extension of the Bliss independence model to pairs: For M drugs, it equals the product of all pair effects to the power 1/(M-1). The pairs model also shows good agreement with previously published data on antibiotic triplets and quadruplets. The present model can only predict combinations at the same doses in which the pairs were measured and is not able to predict effects at other doses. This study indicates that pair-based approaches might be able to usefully predict and prioritize high-order combinations, even in large screens or when material for testing is limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.